Complete Health Improvement Program for Geisinger Health Plan Members With Type 2 Diabetes
Completed · Not applicable
Conditions studied: Type 2 Diabetes
In brief
The Complete Health Improvement Program (CHIP) is a lifestyle improvement program intended to prevent and/or manage cardiovascular disease, diabetes, and other health conditions. This is a pilot-scale randomized-controlled trial comparing the clinical, utilization, and financial outcomes of adult health plan members with type 2 diabetes mellitus (T2DM) offered CHIP versus those only offered standard health plan coverage. We hypothesize that Geisinger Health Plan (GHP) members with T2DM offered CHIP in addition to standard insurance coverage will have improvement in HbA1c and improvements in other biometrics, biomarkers, psychometrics and utilization/financial outcomes, including LDL-C, systolic blood pressure, body mass index, waist circumference, number of diabetes medications prescribed, Wellbeing360 survey, and total cost of healthcare.
Key facts
- Study ID
- NCT04924400
- Run by
- Thomas Morland
- People needed
- 38
- Starts
- 2022-03-09
- Expected to finish
- 2023-01-10
- Last updated by the study team
- 2025-03-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Geisinger Health Plan member for a full year prior to enrollment in the study, with plans to remain covered for a full year after the first study visit
- HbA1c resulted within a year of enrollment in the study
- ≥ 18 years
- Current type 2 diabetes diagnosis
- Living in the five-county region served by the Miller Center (Lycoming, Montour, Northumberland, Snyder and Union) with the ability to arrange their own transportation to the Miller Center in Lewisburg at least 10 times in a 3-month period
- Access to computer, phone, or tablet with sufficient internet to complete program activities.
You may not qualify if…
- Presence of medical condition requiring specific diet (e.g., Celiac disease, phenylketonuria)
- Presence of medical condition contraindicating participation in CHIP, as determined by the Principal Investigator (e.g. cancer on active treatment)
- Pregnancy or plan to become pregnant within one year
- Inability to give informed consent due to mental or psychiatric impairment
- Participation in the Fresh Food Farmacy program
Where it is running
- Geisinger — Danville, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.